Recursion Pharmaceuticals Inc (RXRX)

05:34 AM

Using Bollinger Bands to evaluate Recursion Pharmaceuticals Inc.Trade Exit Summary & Safe Entry Zone Identification - newser.com

05:34 AM

01:41 AM

How Recursion Pharmaceuticals Inc. stock reacts to bond yieldsEarnings Beat & Intraday High Probability Alerts - newser.com

01:41 AM

Nov 03, 2025

AI in pharmaceuticals Market Is Booming Worldwide | Major Giants - openPR.com

Nov 03, 2025

Nov 03, 2025

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? - Yahoo Finance

Nov 03, 2025

Nov 03, 2025

How to interpret RSI for Recursion Pharmaceuticals Inc. stockTreasury Yields & Proven Capital Preservation Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Will earnings trigger a reversal in Recursion Pharmaceuticals Inc.July 2025 Fed Impact & High Yield Stock Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Is Recursion Pharmaceuticals Inc. stock poised for growthWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com

Nov 03, 2025

Nov 03, 2025

How Recursion Pharmaceuticals Inc. stock valuations compare to rivals2025 AllTime Highs & High Conviction Trade Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Will Recursion Pharmaceuticals Inc. stock maintain growth storyQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

When is the best time to exit Recursion Pharmaceuticals Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025

Nov 02, 2025

Biotech Stocks To Add to Your WatchlistOctober 30th - MarketBeat

Nov 02, 2025

Nov 02, 2025

Is it time to cut losses on Recursion Pharmaceuticals Inc.July 2025 News Drivers & Daily Profit Maximizing Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Top Biotech Stocks To Follow TodayNovember 1st - MarketBeat

Nov 02, 2025

Nov 02, 2025

Can Recursion Pharmaceuticals Inc. stock hit record highs againStock Surge & Real-Time Market Sentiment Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Recursion Pharmaceuticals (RXRX) Stock: CEO Sells $5.8 Million in Shares Following Exscientia Merger - CoinCentral

Nov 02, 2025

Nov 01, 2025

Top Biotech Stocks To Keep An Eye OnOctober 28th - MarketBeat

Nov 01, 2025

Nov 01, 2025

Best Biotech Stocks To Follow TodayOctober 31st - MarketBeat

Nov 01, 2025

Nov 01, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Partnerships - Quiver Quantitative

Nov 01, 2025

Oct 31, 2025

Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersGlobal Markets & Free High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

Has Recursion Pharmaceuticals Inc. formed a bullish divergenceVolume Spike & Real-Time Price Movement Reports - newser.com

Oct 31, 2025

Oct 30, 2025

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech

Oct 30, 2025

Oct 30, 2025

Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline - sharewise.com

Oct 30, 2025

Oct 29, 2025

Recursion Pharmaceuticals Incannounces Roche's exercise of option for Microglia MapSEC filing - MarketScreener

Oct 29, 2025

Oct 29, 2025

Roche Exercises Option with Recursion Pharmaceuticals - TipRanks

Oct 29, 2025

Oct 29, 2025

Recursion Pharmaceuticals Announces Roche's Option Exercise - TradingView

Oct 29, 2025

Oct 29, 2025

Published on: 2025-10-29 07:02:21 - newser.com

Oct 29, 2025

Oct 29, 2025

Recursion Pharmaceuticals (RXRX) to Release Quarterly Earnings on Wednesday - MarketBeat

Oct 29, 2025

Oct 29, 2025

Is Hindustan Media Ventures Limited Stock Poised for a Breakout in YEARVolume Weighted Average Price & Master Stock Selection - earlytimes.in

Oct 29, 2025

Oct 28, 2025

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors - sharewise.com

Oct 28, 2025

Oct 28, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Oct 28, 2025

Oct 28, 2025

Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo

Oct 28, 2025

Oct 28, 2025

Recursion Pharmaceuticals (RXRX): Exploring Valuation as AI Expansion, Key Merger, and Clinical Progress Boost Interest - simplywall.st

Oct 28, 2025

Oct 28, 2025

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th - MarketScreener

Oct 28, 2025